Comparison of the cure rates of post-operative regime of topical medication (Moxifloxacin 0.5% and Prednisolone 1%) at 2 weeks and 6 weeks in cataract patients undergoing in uncomplicated Phacoemulsification.

Comparison of the post-operative regime of topical medication in uncomplicated Phacoemulsification at 2 weeks and 6 weeks - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093513

Enrollment

180

Registered

2025-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H259- Unspecified age-related cataract Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Post operative Topical Moxifloxacin 0.5% and Prednisolone 1% combination for 2weeks (6 times for 1 week followed by 4 times for 1 week): Post operative topical Moxifloxacin0.5% and Pred

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with cataract undergoing uncomplicated surgery (Phacoemulsification). 2. Patients who give consent.

Exclusion criteria

Exclusion criteria: 1.Patients with previous corneal disease, corneal trauma, or intraocular surgery. 2. Patients who had communication problems (short of hearing, language barriers, dementia, etc.). 3. Patients with glaucoma or uveitis 4. Patients with Diabetic Retinopathy, Hypertensive Retinopathy or any other macular disease 5. Use of ocular medication during or within 30 days prior to the enrollment. 6. Use of steroid during the study or within 14 days prior to enrollment. 7. Contraindication to ocular treatment with moxifloxacin and prednisolone 8. Systemic diseases that can interfere with the results of the study (e.g., rheumatoid arthritis, Sj?gren?s syndrome, Beh?et?s disease, systemic lupus erythematosus, scleroderma with major ocular involvement, etc.);

Design outcomes

Primary

Measure	Time frame
Reduction in the post operative duration of topical medication from 6 weeks to 2 weeks.Timepoint: 2 weeks	—

Secondary

Measure	Time frame
1.Lesser postoperative side effects like secondary glaucoma, delayed healing & antibacterial resistance. 2. Better patient compliance Timepoint: 2 weeks & 6 weeks	—

Countries

India

Contacts

Public ContactDr Shambhavi Jhobta

Indira Gandhi Medical College and Hospital

rls_10@rediffmail.com9418200098

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026